Vexev
Latest round
- Seed
Last raised
- Jan 2022
Total raised
- $4.6M
Investors
- 3
About Vexev
Based in Australia, Vexev Pty Ltd develops vascular imaging technology for the assessment and monitoring of vascular access and blood flow. Co- Founded in 2018 by Dr John Carroll (CEO) and Dr Eamonn Colley (CEO), the company develops autonomous vascular imaging solutions for healthcare providers. Vexev Pty Ltd develops vascular imaging solutions. Its product, VxWave, is an autonomous ultrasound system that uses robotics, machine learning, and ultrasound technology to support vascular imaging. The system is designed for use in vascular access assessment and monitoring, including applications for dialysis patients. Vexev serves healthcare providers, dialysis centers, and healthcare institutions in the United States.
Who invested in Vexev
3 investors across 2 rounds
See all investors in Vexev
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vexev
Who invested in Vexev?
Vexev has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vexev raised?
Vexev has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Vexev last raise money?
Vexev's most recent round on record is a Seed, in Jan 2022.
What does Vexev do?
Based in Australia, Vexev Pty Ltd develops vascular imaging technology for the assessment and monitoring of vascular access and blood flow.
Where is Vexev headquartered?
Vexev is headquartered in Australia.
Which VCs invest in companies like Vexev?
Among active investors with capital left to deploy, Blackbird, AirTree Ventures, Square Peg and Immutable Ventures back medical devices & equipment companies at Vexev's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like Vexev? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.